MedPath

Examining the efficacy of online cognitive behaviour therapy with different levels of therapist support

Not Applicable
Completed
Conditions
1. Depression 2. Generalized Anxiety Disorder 3. Panic Disorder 4. Social Phobia
Mental and Behavioural Disorders
Registration Number
ISRCTN14230906
Lead Sponsor
niversity of Regina
Brief Summary

2017 results in https://www.ncbi.nlm.nih.gov/pubmed/28964994 (added 25/03/2019)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
180
Inclusion Criteria

1. Resident of Saskatchewan and will be in Saskatchewan during the 8 week course period.
2. Aged 18 years or older, either sex
3. Experiencing symptoms of depression and/or anxiety
4. Has access to a computer and the Internet
5. Has a score of >4 on the Phq-9 or GAD-7
6. Has an interest in the Wellbeing Course

Exclusion Criteria

1. Not a resident of Saskatchewan
2. Less than 18 years of age
3. Has no regular access to a computer, Internet, and use of printer
4. Currently receiving regular psychotherapy for depression or anxiety elsewhere or in some other form
5. Is unwilling to have their physician, a medical clinic, or an emergency hospital be notified of their participation in the program
6. High current risk of suicide or attempt in past year
7. Is experiencing unmanaged symptoms psychosis or mania
8. Alcohol or drug problem that requires primary treatment
9. Hospitalization for mental health problem in past year
10. Does not complete online or telephone screening
11. Does not consent to treatment or complete pre-treatment questionnaires

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> Primary outcome measures are administered at baseline (pre-treatment), before each lesson, immediately following completion of the program, and 3 months following completion of the program.<br><br> 1. Depressive symptoms are measured using the Patient Health Questionnaire- 9 Item (PHQ-9).<br> 2. Symptoms of generalized anxiety are measured using the Generalized Anxiety Disorder -7 Item (GAD-7)<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath